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Abstract
Background—In rural settings, HIV-infected pregnant women often live significant distances 
from facilities that provide prevention of mother-to-child transmission (PMTCT) services.
Methods—We implemented a pilot project to offer universal maternal combination antiretroviral 
regimens in 4 clinics in rural Zambia. To evaluate the impact of services, we conducted a 
household survey in communities surrounding each facility. We collected information about HIV 
status and antenatal service utilization from women who delivered in the past two years. Using 
household global positing systems coordinates collected in the survey, we measured Euclidean 
(i.e., straight line) distance between individual households and clinics. Multivariable logistic 
regression and predicted probabilities were used to determine associations between distance and 
uptake of any PMTCT regimen and combination antiretroviral regimens specifically.
Results—From March to December 2011, 390 HIV-infected mothers were surveyed across four 
communities. Of these, 254 (65%) had household geographical coordinates documented. 168 
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women reported use of a PMTCT regimen during pregnancy, including 102 who initiated a 
combination antiretroviral regimen. The probability of PMTCT regimen initiation was highest 
within 1.9 km of the facility and gradually declined. Overall, 103 of 145 (71%) who lived within 
1.9 km of the facility initiated PMTCT, versus 65 of 109 (60%) who lived farther away. For every 
kilometer increase, the association with PMTCT regimen uptake (adjusted odds ratio [AOR]: 0.90, 
95%CI: 0.82—0.99) and combination antiretroviral regimen uptake (AOR: 0.88, 95%CI: 0.80—
0.97) decreased.
Conclusions—In this rural African setting, uptake of PMTCT regimens was influenced by 
distance to health facility. Program models that further decentralize care into remote communities 
are urgently needed.
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INTRODUCTION
Provision of antiretroviral therapy has yielded significant gains in the prevention of mother-
to-child transmission of HIV (PMTCT) worldwide.1 Combination antiretroviral regimens 
markedly reduce HIV transmission during pregnancy and breastfeeding, with rates less than 
5%.2–5 As recommended by the World Health Organization, the so-called “Option B” 
approach provides universal combination antiretroviral regimens starting at 14 weeks 
gestation and continues until cessation of breastfeeding.6, 7 Many countries have adopted 
this strategy as national policy and, in fact, some have extended it to lifelong antiretroviral 
therapy for all HIV-infected pregnant women (i.e., Option B+).8 Despite their ambitious 
scope, however, the impact of such strategies may be attenuated by inadequate and unequal 
access to comprehensive PMTCT services.9
Geographical barriers, including transportation costs and physical distance to clinic, may 
reduce healthcare access, particularly in rural settings.10–15 Distance estimates have often 
been based on self-report, 16, 17 but such measures can be imprecise and biased.18 While 
more advanced geographical methods have been used to examine distance in relation to 
general HIV care, the impact of distance on antenatal care has not been extensively studied; 
however, available studies suggest that distance does not influence timing of first visit or 
frequency of visits.19, 20 Because HIV itself is potentially stigmatizing and because of the 
additional visits required to minimize HIV transmission from mother to infant, results from 
antenatal studies may not apply directly to PMTCT access. To date, few have examined this 
potential relationship, particularly in the context of universal maternal antiretroviral therapy. 
As national programs seek to “virtually eliminate” pediatric AIDS,21 barriers to Option B/B
+ uptake in the field must be clearly identified. In this report, we examine geospatial patterns 
of combination antiretroviral regimen use in four rural Zambian communities, to better 
understand the role of distance in the uptake of PMTCT services at the population level.
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The Kafue PMTCT Pilot Program
In 2009, we implemented a four-site pilot program in Zambia’s rural Kafue District, 
approximately 50 km south of the capital city of Lusaka. Designed before the 2010 World 
Health Organization guidelines for PMTCT,6 we offered what would later become Option B 
(universal combination antiretroviral regimens to HIV-infected women through pregnancy 
and breastfeeding) in a very under-resourced, rural setting. These services have been 
described elsewhere.22 Briefly, women testing HIV-positive were immediately evaluated for 
HIV treatment eligibility based on CD4 screening and clinical staging. Women who met 
Zambian national guidelines criteria for eligibility to initiate HIV treatment (CD4 count of 
<350 cells/μL or WHO clinical stage of 3 or 4) started lifelong antiretroviral therapy 
immediately. Women who did not meet these criteria were offered combination antiretroviral 
regimens, which started at 28 weeks gestation and continued until the cessation of 
breastfeeding. Women who declined combination antiretroviral regimens were offered 
PMTCT according to the Zambian national guidelines at the time, which recommended 
zidovudine [ZDV] monotherapy from 28 weeks of gestation with peripartum single-dose 
nevirapine [NVP] to mother and neonate, and no additional antiretroviral prophylaxis during 
breastfeeding.23 Women presenting to antenatal care after 28 weeks were initiated 
accordingly at time of presentation.
Survey design and data collection
A cross-sectional household survey was conducted to evaluate the community impact of the 
pilot program on infant HIV-free survival. A full description of the primary methods has 
been published elsewhere.24 Two survey rounds were conducted: the first was implemented 
prior to the pilot program and the second was implemented two years later. Households were 
eligible to be surveyed if a current member was reported to have given birth in the last 24 
months. This population comprised women who lived in the clinic catchment area, but may 
or may not have sought care through the pilot PMTCT program. Written informed consent 
was obtained and a 165-question survey was administered. The survey captured household 
demographic and wealth characteristics, and medical history of the child’s mother. Blood 
specimens were collected from eligible mothers and children for HIV testing.24 For the 
current analysis, we evaluated only those data from the “post-implementation” survey, as it 
was the only round in which household Global Positioning Systems (GPS) coordinates were 
collected. This study was approved by ethical review committees at the University of 
Zambia (Lusaka, Zambia) and the University of North Carolina at Chapel Hill (Chapel Hill, 
NC, USA).
Statistical Analysis
Our study population comprised women who reported a delivery in the past two years and 
tested positive for HIV infection. Our primary outcome of interest was self-reported uptake 
of a PMTCT regimen. We also looked specifically at uptake of a combination antiretroviral 
regimen. Categorical variables were compared using Pearson’s chi-squared test; continuous 
variables were compared using Wilcoxon rank-sum test or a two-sample t-test. We compared 
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the proportion of PMTCT uptake across the four clinics and between individuals with and 
without GPS coordinates to test for bias.
Geospatial patterns of community level uptake of any PMTCT regimen and combination 
antiretroviral regimen among HIV-infected mothers were examined using kernel density 
estimates.25 As part of this methodology, a roving window or kernel with a 1 km radius is 
passed across the study area, and the density of events is computed within the window. 
Density was estimated at the window centroid and was based on the weighted values of all 
events in the window, with greater weight assigned to events near the center. We selected 
this approach to visually examine geographical patterns of access represented as the density 
of uptake per square kilometer, while protecting participant confidentiality. We then 
measured Euclidean distances (i.e., straight line distance; does not account for topographical 
features) to clinic and to the main road for all households. Density estimates and distance 
calculations were computed and mapped using ArcGIS version 10.0 (Environmental 
Systems Research Institute, Redlands, USA). We determined associations between clinic 
distance and our outcomes of interest using logistic regression with clustered robust standard 
errors to correct for correlation among observations from mothers surveyed for more than 
one child. We tested for within site correlation using the intraclass correlation coefficient, to 
ensure that a hierarchical model was not necessary (none detected) and therefore included 
health facility as a dummy variable. Variables selected a priori for inclusion in multivariable 
models included distance to clinic, maternal age, parity, education, institutional delivery, and 
household wealth. We also considered distance to main road, maternal employment, time of 
initial antenatal visit, and knowledge of HIV prior to the survey as factors associated with 
uptake of any PMTCT regimen or combination antiretroviral regimen at a statistical 
significance level of p<0.10. A categorical household wealth variable comprising multiple 
household variables was generated using principal components analysis.26 Household 
wealth reflects a composite of seven binary variables of ownership of household assets 
(phone, television, refrigerator, pit/flush toilet, piped water) and a finished floor. We divided 
the composite score into quintiles with higher quintiles reflecting higher wealth.26 We 
plotted predicted probabilities from the logistic regression models to examine uptake 
patterns as a function of distance to clinic. In primary analysis, we included data from all 
four communities. Because one site had significantly lower ascertainment for GPS 
information (see below), we also conducted a sensitivity analysis whereby that community 




Between March and December 2011, 5801 households were approached, and 2441 (42%) 
households were found to be eligible. A total of 2,444 women from eligible households were 
enrolled in the community survey, of which 390 (16%) were HIV-infected. Of these, 254 had 
household geographical coordinates successfully documented. This varied greatly by 
community. Three had ≥80% ascertainment of GPS information sites (Chipapa 93%, Kafue 
Mission 80%, Mt. Makulu 97%); a fourth (Kafue Estates) had comparatively low 
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ascertainment at 25%. Overall, the proportion of participants reporting initiating a PMTCT 
regimen did not significantly differ between those with available geographical coordinates 
and those without (66% vs. 68%, p= 0.76). Proportions of reported combination 
antiretroviral use did not differ according to available coordinates either (40% vs. 37%, p= 
0.47). Comparisons of other demographic and medical information are shown in 
Supplemental Table 1.
Overall, 168 (66%) reported uptake of any PMTCT regimen during pregnancy, 61% of who 
(n=102) initiated a combination antiretroviral regimen. Within each community, uptake of 
any PMTCT regimen reached as high as 78% (Kafue Estates); reported use of maternal 
combination regimens reached only 46% (Mt. Makulu). Areas with high density estimates of 
uptake were located near health centers, and generally declined in more remote areas (Figure 
1). When compared to those who did not access PMTCT services, those initiating a PMTCT 
regimen were older, had higher parity and education, had prior knowledge of their HIV 
status, attended an ANC clinic for their previous pregnancy, delivered in a health institution, 
and lived near a health facility. Household wealth was not associated with uptake of PMTCT 
regimens.
The median distance for a patient reporting any PMTCT regimen was 1.9 km and ranged 
from <1 km to 20 km. Patients who did not report any PMTCT lived as far as 24 km from a 
clinic (Table 1). Women receiving combination antiretroviral regimens had similar 
characteristics to women receiving any PMTCT regimen (Table 1). Clinic distance ranged 
from <1 km to 15 km, with a median of 1.8 km, among patient’s initiating a combination 
antiretroviral regimen.
Uptake of any PMTCT regimen
Greater distance to clinic was significantly associated with reduced uptake of a PMTCT 
regimen in bivariable (odds ratio [OR]: 0.90, 95% confidence interval [CI]: 0.84, 0.97) and 
multivariable (adjusted OR: 0.90, 95%CI: 0.82, 0.99) models. Each one-kilometer increase 
in distance was associated with a 10% reduced odds for PMTCT regimen uptake. Findings 
were consistent in sensitivity analyses limited to communities with high ascertainment of 
GPS information (adjusted OR: 0.90, 95%CI: 0.82, 0.99). This model suggested that women 
who were older, had obtained education beyond primary school, and who delivered at a 
facility were more likely to have taken up a PMTCT intervention (Table 2). The probability 
of initiating any PMTCT was highest among participants living within 1.9 km of the facility 
and steadily declined with increased distance (Figure 2A). Overall, 103 of 145 (71%) who 
lived within 1.9 km of the facility initiated PMTCT, compared to 65 of 109 (60%) who lived 
farther away.
Uptake of combination antiretroviral regimens
As the distance between clinic and household increased by one kilometer, the odds for 
combination antiretroviral regimen uptake decreased in bivariable (OR: 0.89, 95%CI: 0.82, 
0.97) and multivariable (adjusted OR: 0.88, 95%CI: 0.80, 0.97) models. Each one-kilometer 
increase in distance was associated with a 12% decreased odds for combination 
antiretroviral regimen uptake. Findings were consistent in sensitivity analyses limited to 
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communities with high ascertainment of GPS information (adjusted OR: 0.87, 95%CI: 0.78, 
0.96). Our model suggested that older women were more likely to uptake a combination 
antiretroviral regimen, while those who initiated antenatal care later in pregnancy were less 
likely (Table 2). The probability of initiating a combination antiretroviral regimen declined 
gradually as distance increased. The probability of initiating a combination antiretroviral 
regimen was highest among participants living within 1.9 km of the facility and steadily 
declined with increased distance (Figure 2B). Overall, 65 of 145 (45%) who lived within 1.9 
km of the facility initiated PMTCT, compared to 37 of 109 (34%) who lived farther away.
DISCUSSION
We observed reduced uptake of PMTCT services, including maternal combination 
antiretroviral regimens, as the distance between home and clinic increased. Uptake of 
PMTCT was highest within 1.9 km of a clinic and steadily declined as distance increased. 
This finding is consistent with previous work in the field of HIV treatment, where long 
distance and travel costs are recognized barriers to care and treatment in resource-
constrained settings.10, 12, 15 However, it contrasts past studies of antenatal care, in which 
distance did not appear to influence the timing or frequency of antenatal visits.19, 20 We 
expected this contrast due to potential fear of stigma associated with PMTCT uptake.14 
Since PMTCT bridges these two health services, dedicated studies such as this – focused on 
PMTCT utilization at the population level – provide important supporting evidence for the 
design of future programs.
We used precise GPS household location information, which allowed us to calculate distance 
from home to clinic and examine geospatial patterns of uptake. However, we were unable to 
measure path distance – or to estimate travel time – to clinic because of limited data on the 
rural road network in our study area. Instead, we used Euclidean distance, which has been 
found to be highly correlated with path distance in other rural settings.18, 27 In addition, we 
did not have the necessary data to weight distance measures by costs associated with travel 
(e.g., car, bus, bicycle, foot). This analysis thus assumes that potential modes of 
transportation have no influence on PMTCT uptake, which may not be realistic,28 since cost 
would likely increase with distance.
More than one-third of the GPS coordinates were missing from participating households. 
This is a potential limitation of this analysis; if this missing data was not at random, it could 
unduly bias the study results. To address this issue, we compared individuals with and 
without recorded GPS coordinates and found that there were few differences between these 
populations, including by uptake of PMTCT services. Missing data appeared to be 
concentrated in the Kafue Estates community, due to technical difficulties with the 
instruments themselves that were discovered only after the survey had finished. When we 
excluded this single site in a sensitivity analysis, we were reassured to find that the results 
were consistent. While not definitive, these supporting analyses do provide a degree of 
reassurance about our primary findings.
Negative perceptions about clinical care and fear of stigma, could have been associated with 
service uptake in the antenatal setting.14, 29 It is also possible that the use of self-reported 
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PMTCT uptake measures influenced our primary outcome. These factors may explain the 
overall low uptake of services, with fewer than 50% of participants receiving combination 
antiretroviral regimens, and more than 30% never initiating PMTCT at all. However, we 
were unable to examine potential cultural or social factors that may influence a mother’s 
decision to start a PMTCT regimen. Mixed methods approaches may be of particular 
promise for future work, as program managers and researchers seek to identify and 
understand the host of potential obstacles for PMTCT service utilization. Such formative 
work is critical to the design of interventions and implementation strategies appropriate to 
the local context.
Long distance and travel costs have been linked to poor program outcomes among HIV-
infected adults in several settings, and are recognized barriers to HIV testing, timely 
antiretroviral therapy initiation, and consistent drug adherence.30–33 The impact of distance 
in this PMTCT context is particularly important, as PMTCT and general HIV treatment 
become increasingly aligned through innovative strategies such as Option B+. Interestingly, 
our distance threshold of 1.9 kilometers – after which the uptake of PMTCT services 
steadily declined – is similar to those observed in other settings. In South Africa, for 
example, ART uptake was highest among individuals living within 1 km of a health facility, 
after which a decline in uptake was observed.34 In Kenya, clients living within 1 km of the 
main road (correlated with hospital distance) were less likely to be lost to follow up after 
registering for HIV care, compared to individuals living 1–5 km and >5 km from the main 
road.35 This distance threshold is important to consider in planning for health care 
availability, as it appears to apply across diverse settings in sub-Saharan Africa.
Several aspects of our pilot program may have influenced PMTCT uptake. We incorporated 
CD4 screening and triage, as mandated by the Zambian national guidelines.23 CD4 
evaluation significantly delays antiretroviral therapy initiation during pregnancy in many 
settings.36 Guided by national guidelines 23 to initiate ZDV at 28 weeks gestation, we waited 
until at least 28 weeks gestation to start combination antiretroviral regimens for those 
women who did not immediately qualify for antiretroviral therapy based on maternal health. 
Thus, those who presented early in pregnancy and learned their HIV status were required to 
return later in pregnancy to start combination prophylaxis. The need for a second visit may 
have negatively influenced uptake. While newer PMTCT policies for Option B/B+ largely 
address these bottlenecks (e.g., antiretroviral therapy initiation from 14 weeks onward, 
elimination of CD4 triage) – and thus should improve uptake of services – distances between 
home and clinic will continue to have an important and ongoing role in drug adherence and 
clinical care engagement.
Our pilot program integrated HIV treatment within the framework of maternal-child health 
services, a strategy that has been shown to increase the timely initiation of antiretroviral 
therapy among pregnant women.36, 37 However, decentralization to primary care settings 
alone may not be enough to maximize coverage of services. In rural settings, new models 
may be needed to extend the existing health system. Mobile clinics, for example, have been 
shown to be effective for ongoing monitoring and drug distribution.38 Community health 
workers and other outreach personnel can also reliably increase service uptake, enhance 
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adherence (through counseling and drug delivery), and improve program retention over 
time.39, 40
In summary, we observed an important association between home-to-clinic distance and 
uptake of PMTCT services. These results are consistent with other studies in the HIV 
treatment literature, and highlight the need for greater investments in health infrastructure 
beyond primary health care facilities and into communities. As national programs seek to 
further reduce the number of new pediatric HIV infections, the enhancement of existing 
PMTCT services must be accompanied by new strategies to decentralize care and maximize 
coverage across rural and remote settings.
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Kernel density estimates representing the number of HIV-infected women per km2 who 
initiated PMTCT regimens. Clusters on the map represent all HIV-infected mothers who 
participated in the survey. The light peach clusters demarcate areas with zero uptake of 
PMTCT services, while the light and dark orange clusters represent areas where density of 
PMTCT uptake ranged from 1 to 10 persons per km2. The dark orange clusters represent 
uptake of combination antiretroviral regimens only, ranging from 1 to 10 persons per km2. 
Overall, areas with high density estimates of uptake were located near health centers, and 
declined in rural areas. The highest density estimates of uptake ranged from 10 to 20 per 
km2 near Kafue Estates Health Centre and Chipapa Rural Health Centre (demarcated by 
gray circle).
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Predicted probabilities of initiating PMTCT estimated from multivariable logistic regression 
models. The probability of initiating any PMTCT regimen was highest among participants 
living within 1.9 km of the facility and declined steadily with distance. Wider confidence 
intervals are observed at greater distances where few participants reported PMTCT. The 
probability of initiating a combination antiretroviral regimen had a steeper decline as 
distance increased due to zero uptake among participants living beyond 15 km.
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